Ezintsha

What Ezintsha does

Ezintsha is a multidisciplinary research center headquartered in Johannesburg, South Africa, founded in 2019. The organization operates in the clinical research domain with stated specialization in three interconnected activities: clinical trials, medical technologies, and research publications. With a workforce of 101-250 employees, it operates at a scale consistent with mid-sized clinical research organizations (CROs) or research-focused academic-industry hybrid entities, with the bandwidth to run multi-site trials in parallel and to maintain an in-house publication program.\n\nThe company's stated focus on clinical trials implies engagement in the design, execution, and management of human-subject studies, with plausible customer cohorts including pharmaceutical sponsors, biotechnology firms, medical device manufacturers, public-health agencies, and non-governmental research funders. The medical technologies dimension suggests involvement in the evaluation, validation, or development of medical devices and related health technologies, including potential regulatory or clinical evidence work supporting product approvals. The research publications component signals contribution to peer-reviewed scientific literature, indicating the center employs credentialed researchers and clinician-scientists capable of producing original clinical evidence—a capability that often underpins investigator credibility and sponsor selection in the CRO space.\n\nThe business model, pricing structure, go-to-market, and revenue mechanics for Ezintsha are not disclosed in available source data, representing a material information gap. Typical revenue models for organizations of this type and scale include per-trial or per-protocol fees from commercial sponsors, government and multilateral grant funding, research contracts with academic medical centers, and royalty or milestone participation in co-developed medical technologies. Its geographic base in Johannesburg positions the firm in a regional hub for African clinical research, addressing locally-relevant disease burden and the demand for trial population diversity—factors that are increasingly valued by global pharma sponsors seeking African site representation.

Name

Ezintsha

Website

https://ezintsha.org

Company type

Private

Founded year

2019

Headcount range

101–250 employees

Short description

Ezintsha is a Johannesburg, South Africa-based multidisciplinary research center founded in 2019, specializing in clinical trials, medical technologies, and peer-reviewed research publications, and currently operating with 101-250 employees serving healthcare research clients.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

akta.pro secondary industries

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)

Keywords

• Clinical trials research
• Medical technology research
• Clinical research services
• Health research publications
• Multidisciplinary research center

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Others

Core offering

Ezintsha is a multidisciplinary research center that conducts clinical trials, performs research in medical technologies, and produces research publications. The organization operates as a for-profit research entity based in Johannesburg, South Africa, with 101-250 employees, supporting sponsor and partner organizations requiring clinical and medical-technology research services.

Product overview

No product information available. The source data shows only a loading/verification screen with no substantive company or product content.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• Parexel: Global CRO providing clinical trial management, biostatistics, and regulatory consulting. Comparable on the clinical-trial services core that Ezintsha delivers.
• ICON plc: Large global CRO offering clinical-trial operations, lab services, and post-approval research. Comparable as a broad incumbent that Ezintsha would subcontract with or compete against for sponsor work.
• IQVIA: Global CRO and clinical-trial services leader with substantial African site footprint. Comparable as the dominant incumbent competing for the same sponsor contracts Ezintsha targets.
• Charles River Laboratories: Provides research models, preclinical and clinical lab services, and trial support. Comparable on the research-services and laboratory capabilities that overlap with Ezintsha's medtech/research work.
• Syneos Health: Biopharma solutions organization offering clinical development and commercialization services. Comparable as a CRO peer competing for the same clinical-trial mandates.
• FHI 360: Global human-development organization running clinical and public-health research programs, including in Africa. Comparable on multidisciplinary health research and clinical-trial execution.

Direct peers

• Aurum Institute: South African health-research organization running clinical trials, TB/HIV research programs, and publishing peer-reviewed work. Closely comparable to Ezintsha on geography, multidisciplinary research scope, and clinical-trials focus.

Regional players

• The Africa Clinical Research Network (ACRN): Africa-focused clinical trial site network. Comparable as a regional alternative to Ezintsha for sponsors seeking trial execution on the continent.
• Lancet Laboratories: Major South African diagnostic and clinical laboratory network. Comparable on the laboratory-services and clinical-research testing dimension relevant to trial work.
• Desmond Tutu Health Foundation: South Africa-based research organization conducting HIV/TB clinical trials and publishing associated research. Comparable on the regional clinical-research and publications mission.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/ezintsha
• LinkedInlinkedin.com/company/ezintsha

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ezintsha